ALLARITY THERAPEUTICS, INC. SECURITY AGREEMENTSecurity Agreement • June 30th, 2023 • Allarity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Security Agreement (this “Agreement”) is made as of June 29, 2023, by Allarity Therapeutics, Inc, a Delaware corporation (“Allarity”) and Allarity Acquisition Subsidiary, Inc., a Delaware Corporation (the “Allarity Acquisition Sub”, and together with Allarity, the “Company”), in favor of 3i, LP. a Delaware limited partnership (the “Holder”).
ALLARITY THERAPEUTICS, INC. SECURED NOTE PURCHASE AGREEMENTSecured Note Purchase Agreement • June 30th, 2023 • Allarity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Secured Note Purchase Agreement dated as of June 29, 2023 (this “Agreement”), is entered into by and among Allarity Therapeutics, Inc. (the “Company”), and the entity listed on the schedule of investors attached hereto as Schedule I (the “Investor”).
